Platelet Transfusions in Infants with Necrotizing Enterocolitis Do Not Lower Mortality but May Increase Morbidity

Kenton, Alexander B; Hegemier, Suzanne; Smith, E O'Brian; O'Donovan, Donough J; Brandt, Mary L; Cass, Darrell L; Helmrath, Michael A; Washburn, Kimberly; Weihe, Elizabeth K; Fernandes, Caraciolo J
March 2005
Journal of Perinatology;Mar2005, Vol. 25 Issue 3, p173
Academic Journal
OBJECTIVE:: Necrotizing enterocolitis (NEC), a serious multisystemic inflammatory disease most commonly seen in premature neonates, is often associated with thrombocytopenia. Infants with severe forms of NEC commonly have platelet counts of less than 50,000/mm3, occasionally less than 10,000/mm3. Despite an absence of data to support the practice, platelet transfusions are commonly used to maintain a certain arbitrary platelet count in an effort to prevent bleeding. As platelet transfusions contain a variety of bioactive factors including pro-inflammatory cytokines, we hypothesized that a higher number and volume of platelet transfusions would not be associated with an improvement in mortality or morbidity. STUDY DESIGN:: A retrospective cohort analysis was conducted of the medical records of all infants between 1997 and 2001 with Bell's Stage 2 or 3 NEC associated with platelet counts of<100,000/mm3. The medical records were evaluated for the following variables: platelet counts, number and volume of platelet transfusions, symptoms of bleeding, and hospital course. Mortality and development of short bowel syndrome and/or cholestasis were correlated to the total number and volume (total ml and ml/kg) of platelet transfusions. Differences between the outcome groups were compared using the independent t-test, Fisher's exact test and Mann-Whitney tests. RESULTS:: A total of 46 infants met the study criteria (gestational age 28±4 weeks and birth weight 1166±756?g, mean±SD). There were a total of 406 platelet transfusions administered to the study population. Of these, 151 (37.2%) were given in the presence of active bleeding, with 62%of these resulting in the cessation of bleeding within 24 hours. Other listed indications for platelet transfusions were hypovolemia and severe thrombocytopenia. On analysis of the entire cohort, there was no statistical improvement in either mortality or morbidity (short bowel syndrome and cholestasis) with greater number and/or volume of platelet transfusions. Furthermore, we found that infants who developed short bowel syndrome and/or cholestasis had been given a significantly higher number and volume of platelet transfusions when compared to those who did not have these adverse outcomes[median (minimum-maximum)-number of transfusions : 9 (0 to 33) vs 1.5 (0 to 20), p=0.010; volume of transfusions (ml/kg) : 121.5 (0 to 476.6) vs 33.2 (0 to 224.3), p=0.013]. CONCLUSION:: This retrospective analysis suggests that greater number and volume of platelet transfusions in infants with necrotizing enterocolitis are associated with greater morbidity in the form of short bowel syndrome and/or cholestasis without the benefit of lower mortality.Journal of Perinatology (2005) 25, 173-177. doi:10.1038/sj.jp.7211237 Published online 2 December 2004


Related Articles

  • PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Griesshammer, M.; Klippel, S.; Strunck, E.; Temerinac, S.; Mohr, U.; Heimpel, H.; Pahl, H. L. // Annals of Hematology;Jun2004, Vol. 83 Issue 6, p364 

    Essential thrombocythemia (ET) is a heterogeneous disorder. For example, the growth of erythropoietin-independent erythroid colonies, termed “endogenous erythroid colonies (EECs)”, has previously been observed in only 50% of ET patients. We have recently described the overexpression...

  • Do we know when to treat neonatal thrombocytopaenia? Venkatesh, Vidheya; Curley, Anna E.; Clarke, Paul; Watts, Timothy; Stanworth, Simon J. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2013, Vol. 98 Issue 5, pF380 

    The article offers information related to thrombocytopaenia, which is a condition of relative decrease of platelets in blood. It informs that the thrombocytopaenia is affecting around 25 percent of all neonates admitted to neonatal intensive care units in the U.S. It mentions that platelet...

  • Pulmonary embolism after minor surgery in a patient with low-risk thrombocythemia. Hosoi, Satoshi; Adachi, Takehiko; Hara, Tomoko; Nakagawa, Tatsushi; Sasaki, Yukiko; Hara, Yasushi; Urabe, Nobukata // Journal of Anesthesia;2004, Vol. 18 Issue 2, p146 

    Presents a case of pulmonary embolism after minor surgery in a 54-year-old patient with low-risk thrombocythemia. Information on thrombocythemia; Medical records of the patient; Recommended medical treatment for essential thrombocythemia.

  • Economic Assessment of Thrombocytopenia: CATCH Registry. Eisenstein, Eric L.; Honeycutt, Emily F.; Anstrom, Kevin J.; Becker, Richard C.; Granger, Christopher B.; Rao, Sunil V.; Jolicoeur, Marc E.; Ohman, E. Magnus // Journal of Medical Systems;Jun2010, Vol. 34 Issue 3, p379 

    Thrombocytopenia is associated with increased patient risk. However, the costs of this complication are not well defined. This study assessed the impact of thrombocytopenia on in-hospital costs using results from CATCH, an observational study that examined 1988 consecutive patients receiving...

  • How can we provide the best care for our patients with immune thrombocytopenic pupura? George, James N.; Veseley, Sara K.; Vesely, Sara K // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p456 

    Discusses how physicians can know the best available evidence for treating patients with immune thrombocytopenic purpura (ITP). Comprehensive review on the management of ITP in adults by Stasi and Provan; Objective method of determining expert opinion; Quantitative assessment of responses to...

  • Pseudothrombocytopenia: A Rare Phenomenon. Makris, Pantelis E.; Foka, Zoi; Gerotziafas, Grigoris T.; Kioumi, Anna; Pithara, Eleutheria // Clinical & Applied Thrombosis/Hemostasis;Jul1998, Vol. 4 Issue 3, p167 

    Thrombocytopenia is a serious situation that causes anxiety in doctors due to its relationship with serious hemorrhagic manifestations. Pseudothrombocytopenia, however, is a situation without clinical interest because it is an in vitro decrease in platelet count. Pseudothrombocytopenia is...

  • Bleeding and Other Presentations in Thai Patients with Dengue Infection. Wiwanitkit, Viroj // Clinical & Applied Thrombosis/Hemostasis;Oct2004, Vol. 10 Issue 4, p397 

    Dengue infection is a major public health problem, affecting the general population in Southeast Asia. Hematologic aberrations in dengue infection include atypical lymphocytosis, coagulopathy, and predominant thrombocytopenia. Bleeding and other presentations in 30 Thai patients with dengue...

  • Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII. Brenner, Benjamin; Hoffman, Ron; Balashov, Dmitriy; Shutluko, Elena; Čulić, Srđana; Nizamoutdinova, Elena // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p401 

    This paper presents an analysis of 24 cases in which recombinant factor Vila (rFVIIa) was used in the management of hemorrhage in patients with thrombocytopenia associated with hematologic malignancies. This is the largest case aggregation to date and focuses on preliminary experience in the...

  • A bleeding risk.  // Mayo Clinic Health Letter;Jul2007, Vol. 25 Issue 7, p7 

    The article discusses health risks associated with low platelet count or thrombocytopenia. A low platelet count affect blood's ability to clot causing severe bleeding. Severe bleeding can occur when platelet numbers fall below 30,000 per microliter of circulating blood and the greatest risk is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics